Apollo Hospitals adopts acquisition mode for regional penetration
Apollo Hospitals adopts acquisition mode for regional penetration

Apollo Hospitals adopts acquisition mode for regional penetration

Bhagyashree Vivarekar Article rating: 5.0

Healthcare service provider and pharmacy operator, Apollo Hospitals has acquired 50 per cent stake in Medics International Lifesciences for consideration of Rs. 91 crore through primary issuance of shares by the latter. Medics operates a hospital in Lucknow which is a 330-bed super speciality hospital project.

Indian Benchmark indices outperform Asian peers
Indian Benchmark indices outperform Asian peers

Indian Benchmark indices outperform Asian peers

Rohan Takalkar Article rating: No rating

Trade war fears have shredded significant gains made by investors across global indices. The Asian markets were the worst hit, with Chinese indices losing the most.

How to beat basic mutual fund risks
How to beat basic mutual fund risks

How to beat basic mutual fund risks

Nikhil Desai Article rating: 5.0

All the mutual funds carry some basic types of risks, but this does not mean that investors should avoid investing. The basic risks that every investor faces in the world of investment are volatility, uncertain and credit risk.

Welspun Enterprises bags NHAI order for road project
Welspun Enterprises bags NHAI order for road project

Welspun Enterprises bags NHAI order for road project

Shohini Nath Article rating: 5.0

Welspun Enterprises Limited has secured an order for road project from National Highway Authority of India (NHAI) for four-laning from Sattanathapuram to Nagapattinam in the State of Tamil Nadu under the NHDP Phase-IV on Hybrid Annuity Mode.

Bajaj Auto goes vroom, vroom, bounces back sharply
Bajaj Auto goes vroom, vroom, bounces back sharply

Bajaj Auto goes vroom, vroom, bounces back sharply

Bhagyashree Vivarekar Article rating: No rating

Bajaj Auto surged as much as 3.5 per cent in Friday’s trade, registering more than 13.5 per cent overall gains since its recent lows near 2,705 level on June 28. Robust sales numbers and promotional offers have been discounted in the stock prices and still holds an upside potential.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.50 crore contracts with a turnover of Rs. 15,18,097.53 crore.

Ginger Hotel plans to sell properties to become asset-light
Ginger Hotel plans to sell properties to become asset-light

Ginger Hotel plans to sell properties to become asset-light

Amir Shaikh Article rating: 5.0

With Aspiration 2022 strategy, which the company revealed this year, the Indian Hotel Company is targeting to become asset-light and improve its EBITDA margin to the level of 25 per cent by 2022.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.50 crore contracts with a turnover of Rs. 15,18,097.53 crore.

Glenmark to commercialize Ryaltris in Australia and New Zealand
Glenmark to commercialize Ryaltris in Australia and New Zealand

Glenmark to commercialize Ryaltris in Australia and New Zealand

Apurva Joshi Article rating: 5.0

Glenmark Pharmaceuticals Limited has announced that its subsidiary Glenmark Speciality S.A. has entered into a licensing agreement with Seqirus Pty. Ltd. to commercialize Ryaltris in Australia and New Zealand. Seqirus is a part of an Australian-based speciality biotechnology company, CSL Limited.


RSS
First29342935293629372939294129422943Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR